Association of Fusobacterium nucleatum with immunity and molecular alterations in colorectal cancer
Open accessAbstract
The human intestinal microbiome plays a major role in human health and diseases, including colorectal cancer. Colorectal carcinogenesis represents a heterogeneous process with a differing set of somatic molecular alterations, influenced by diet, environmental and microbial exposures, and host immunity. Fusobacterium species are part of the human oral and intestinal microbiota. Metagenomic analyses have shown an enrichment of Fusobacterium nucleatum (F. nucleatum) in colorectal carcinoma tissue. Using 511 colorectal carcinomas from Japanese patients, we assessed the presence of F. nucleatum. Our results showed that the frequency of F. nucleatum positivity in the Japanese colorectal cancer was 8.6% (44/511), which was lower than that in United States cohort studies (13%). Similar to the United States studies, F. nucleatum positivity in Japanese colorectal cancers was significantly associated with microsatellite instability (MSI)-high status. Regarding the immune response in colorectal cancer, high levels of infiltrating T-cell subsets (i.e., CD3+, CD8+, CD45RO+, and FOXP3+ cells) have been associated with better patient prognosis. There is also evidence to indicate that molecular features of colorectal cancer, especially MSI, influence T-cell-mediated adaptive immunity. Concerning the association between the gut microbiome and immunity, F. nucleatum has been shown to expand myeloid-derived immune cells, which inhibit T-cell proliferation and induce T-cell apoptosis in colorectal cancer. This finding indicates that F. nucleatum possesses immunosuppressive activities by inhibiting human T-cell responses. Certain microRNAs are induced during the macrophage inflammatory response and have the ability to regulate host-cell responses to pathogens. MicroRNA-21 increases the levels of IL-10 and prostaglandin E2, which suppress antitumor T-cell-mediated adaptive immunity through the inhibition of the antigen-presenting capacities of dendritic cells and T-cell proliferation in colorectal cancer cells. Thus, emerging evidence may provide insights for strategies to target microbiota, immune cells and tumor molecular alterations for colorectal cancer prevention and treatment. Further investigation is needed to clarify the association of Fusobacterium with T-cells and microRNA expressions in colorectal cancer.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Fusobacterium nucleatum reduces the anti-tumor immune response.
“supporting studies reporting that F nucleatum reduces the anti-tumor immune response.”
From Influence of the Gut Microbiome, Diet, and Environment on Risk of Colorectal Cancer (2020) · cites this paper as [29]
Fusobacterium nucleatum levels in tumor tissue are associated with lower T cell infiltration.
“Moreover, levels of F nucleatum in tumor tissue have been associated with lower infiltration by T cells,29, 30”
From Influence of the Gut Microbiome, Diet, and Environment on Risk of Colorectal Cancer (2020) · cites this paper as [29]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,989 · see citing works
Adverse Renal Effects of Immune Checkpoint Inhibitors: A Narrative Review
Wanchoo, R., Karam, S., Uppal, N. N., Barta, V. S., Deray, G., Devoe, C., Launay‐Vacher, V., Jhaveri, K. D., & on behalf of Cancer and Kidney International Network Workgroup on Immune Checkpoint Inhibitors (2017) · American Journal of Nephrology · doi:10.1159/000455014 · Cited by 15,314 · see citing works
The blockade of immune checkpoints in cancer immunotherapy
Pardoll, D. M. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3239 · Cited by 13,838 · see citing works
PD-1 blockade induces responses by inhibiting adaptive immune resistance
Tumeh, P. C., Harview, C. L., Yearley, J. H., Shintaku, I. P., Taylor, E. J. M., Robert, L., Chmielowski, B., Spasic, M., Henry, G., Ciobanu, V., et al. (2014) · Nature · doi:10.1038/nature13954 · Cited by 6,609 · see citing works
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
Schreiber, R. D., Old, L. J., & Smyth, M. J. (2011) · Science · doi:10.1126/science.1203486 · Cited by 6,474 · see citing works
Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients
Herbst, R. S., Soria, J.-C., Kowanetz, M., Fine, G. D., Hamid, O., Gordon, M. S., Sosman, J. A., McDermott, D. F., Powderly, J. D., Gettinger, S. N., et al. (2014) · Nature · doi:10.1038/nature14011 · Cited by 5,231 · see citing works
The immune contexture in human tumours: impact on clinical outcome
Fridman, W. H., Pagès, F., Sautès-Fridman, C., & Galon, J. (2012) · Nature reviews. Cancer · doi:10.1038/nrc3245 · Cited by 4,981 · see citing works
Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma
Snyder, A., Makarov, V., Merghoub, T., Yuan, J., Zaretsky, J. M., Desrichard, A., Walsh, L. A., Postow, M. A., Wong, P., Ho, T. S., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1406498 · Cited by 4,286 · see citing works
Nivolumab plus Ipilimumab in Advanced Melanoma
Wolchok, J. D., Kluger, H., Callahan, M. K., Postow, M. A., Rizvi, N. A., Lesokhin, A. M., Segal, N. H., Ariyan, C. E., Gordon, R.-A., Reed, K., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1302369 · Cited by 4,230 · see citing works
Molecular and genetic properties of tumors associated with local immune cytolytic activity
Rooney, M. S., Shukla, S. A., Wu, C. J., Getz, G., & Hacohen, N. (2015) · Cell · doi:10.1016/j.cell.2014.12.033 · Cited by 3,825 · see citing works
Coordinated regulation of myeloid cells by tumours
Gabrilovich, D. I., Ostrand-Rosenberg, S., & Bronte, V. (2012) · Nature Reviews Immunology · doi:10.1038/nri3175 · Cited by 3,544 · see citing works
Kostic, A. D., Chun, E., Robertson, L., Glickman, J. N., Gallini, C. A., Michaud, M., Clancy, T. E., Chung, D. C., Lochhead, P., Hold, G. L., et al. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.07.007 · Cited by 2,718 · see citing works
MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer
Powles, T. B., Eder, J. P., Fine, G. D., Braiteh, F. S., Loriot, Y., Cruz, C., Joaquim Bellmunt, B., Burris, H. A., Petrylak, D. P., Teng, S.-L. M., et al. (2014) · Nature · doi:10.1038/nature13904 · Cited by 2,383 · see citing works
Treatment of HCV Infection by Targeting MicroRNA
Janssen, H. L. A., Reesink, H. W., Lawitz, E., Zeuzem, S., Rodriguez‐Torres, M., Patel, K., van der Meer, A. J., Patick, A. K., Chen, A. P., Zhou, Y., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1209026 · Cited by 2,206 · see citing works
Effector Memory T Cells, Early Metastasis, and Survival in Colorectal Cancer
Pagès, F., Berger, A., Camus, M., Sanchez-Cabo, F., Costes, A., Molidor, R., Mlecnik, B., Kirilovsky, A., Nilsson, M., Damotte, D., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051424 · Cited by 2,135 · see citing works
Regulatory T cells, tumour immunity and immunotherapy
Zou, W. (2006) · Nature reviews. Immunology · doi:10.1038/nri1806 · Cited by 2,075 · see citing works
<i>Fusobacterium nucleatum</i> infection is prevalent in human colorectal carcinoma
Castellarin, M., Warren, R. L., Freeman, J. D., Dreolini, L., Krzywinski, M., Strauss, J., Barnes, R., Watson, P., Allen-Vercoe, E., Moore, R. A., et al. (2012) · Genome Research · doi:10.1101/gr.126516.111 · Cited by 2,043 · see citing works
Genomic analysis identifies association of <i>Fusobacterium</i> with colorectal carcinoma
Kostic, A. D., Gevers, D., Pedamallu, C. S., Michaud, M., Duke, F., Earl, A. M., Ojesina, A. I., Jung, J., Bass, A. J., Tabernero, J., et al. (2012) · Genome Research · doi:10.1101/gr.126573.111 · Cited by 1,960 · see citing works
Landon, M., Saam, J. R., Brown, K. L., Moyes, K., Evans, B. A., & WENSTRUP, R. J. (2015) · Oncology · doi:10.1159/000430097 · Cited by 1,943 · see citing works
Asangani, I. A., Rasheed, S. A. K., Nikolova, D. A., Leupold, J. H., Colburn, N. H., Post, S., & Allgayer, H. (2008) · Oncogene · doi:10.1038/sj.onc.1210856 · Cited by 1,882 · see citing works
Systematic Review of Microsatellite Instability and Colorectal Cancer Prognosis
Popat, S., Hubner, R. A., & Houlston, R. S. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.086 · Cited by 1,830 · see citing works
Wang, D., & DuBois, R. N. (2010) · Nature reviews. Cancer · doi:10.1038/nrc2809 · Cited by 1,794 · see citing works
Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future
Kahn, S. E., Cooper, M. E., & Del Prato, S. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62154-6 · Cited by 1,743 · see citing works
Schwabe, R. F., & Jobin, C. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3610 · Cited by 1,689 · see citing works
Schetter, A. J., Leung, S. Y., Sohn, J. J., Zanetti, K. A., Bowman, E. D., Yanaihara, N., Yuen, S. T., Chan, T. L., Kwong, D. L. �., Au, G. K. �., et al. (2008) · JAMA · doi:10.1001/jama.299.4.425 · Cited by 1,578 · see citing works
Obinutuzumab plus Chlorambucil in Patients with CLL and Coexisting Conditions
Goede, V., Fischer, K., Busch, R. M., Engelke, A., Eichhorst, B. F., Wendtner, C., Chagorova, T., de la Serna, J., Dilhuydy, M., Illmer, T., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1313984 · Cited by 1,522 · see citing works
Llosa, N. J., Cruise, M., Tam, A., Wicks, E. C., Hechenbleikner, E. M., Taube, J. M., Blosser, R. L., Fan, H., Wang, H., Luber, B. S., et al. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-14-0863 · Cited by 1,487 · see citing works
Clinical relevance of circulating cell-free microRNAs in cancer
Schwarzenbach, H., Nishida, N., Călin, G. A., & Pantel, K. (2014) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2014.5 · Cited by 1,091 · see citing works
Therapeutic targeting of microRNAs: current status and future challenges
Li, Z., & Rana, T. M. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4359 · Cited by 1,028 · see citing works
Sheedy, F. J., Palsson-McDermott, E., Hennessy, E. J., Martin, C., O'Leary, J. J., Ruan, Q., Johnson, D. S., Chen, Y., & O'Neill, L. A. J. (2010) · Nature Immunology · doi:10.1038/ni.1828 · Cited by 1,005 · see citing works
Salama, P. R., Phillips, M. R., Grieu, F., Morris, M. J., Zeps, N., Joseph, D. J., Platell, C. F. E., & Iacopetta, B. J. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.7229 · Cited by 992 · see citing works
Cytokine patterns in patients with cancer: a systematic review
Lippitz, B. E. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70582-x · Cited by 906 · see citing works
A bacterial driver–passenger model for colorectal cancer: beyond the usual suspects
Tjalsma, H., Boleij, A., Marchesi, J. R., & Dutilh, B. E. (2012) · Nature Reviews Microbiology · doi:10.1038/nrmicro2819 · Cited by 903 · see citing works
Aspirin Use, Tumor PIK3CA Mutation, and Colorectal-Cancer Survival
Liao, X., Lochhead, P. J., Nishihara, R., Morikawa, T., Kuchiba, A., Yamauchi, M., Imamura, Y., Qian, Z. R., Baba, Y., Shima, K., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1207756 · Cited by 842 · see citing works
The Terminology Issue for Myeloid-Derived Suppressor Cells
Gabrilovich, D. I., Bronte, V., Chen, S., Colombo, M. P., Ochoa, A. C., Ostrand‐Rosenberg, S., & Schreiber, H. W. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3037 · Cited by 834 · see citing works
Iliopoulos, D., Jaeger, S. A., Hirsch, H. A., Bulyk, M. L., & Struhl, K. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.07.023 · Cited by 830 · see citing works
MicroRNA silencing for cancer therapy targeted to the tumour microenvironment
Cheng, C. J., Bahal, R., Babar, I., Pincus, Z., Barrera, F. N., Liu, C. S., Svoronos, A. A., Braddock, D. T., Glazer, P. M., Engelman, D. M., et al. (2014) · Nature · doi:10.1038/nature13905 · Cited by 824 · see citing works
Ogino, S., Nosho, K., Kirkner, G. J., Kawasaki, T., Meyerhardt, J. A., Loda, M. F., Giovannucci, E. L., & Fuchs, C. S. (2008) · Gut · doi:10.1136/gut.2008.155473 · Cited by 772 · see citing works
<i>Fusobacterium nucleatum</i> and T Cells in Colorectal Carcinoma
Mima, K., Sukawa, Y., Nishihara, R., Qian, Z. R., Yamauchi, M., Inamura, K., Kim, S. A., Masuda, A., Nowak, J. A., Nosho, K., et al. (2015) · JAMA Oncology · doi:10.1001/jamaoncol.2015.1377 · Cited by 669 · see citing works
Inflammation and cancer: interweaving microRNA, free radical, cytokine and p53 pathways
Schetter, A. J., Heegaard, N. H. H., & Harris, C. C. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp272 · Cited by 659 · see citing works
Strauss, J., Kaplan, G. G., Beck, P. L., Rioux, K. P., Panaccione, R., DeVinney, R., Lynch, T., & Allen‐Vercoe, E. (2011) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21606 · Cited by 574 · see citing works
Guiducci, C., Vicari, A. P., Sangaletti, S., Trinchieri, G., & Colombo, M. P. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4262 · Cited by 549 · see citing works
Tregs and rethinking cancer immunotherapy
Curiel, T. J. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31202 · Cited by 545 · see citing works
Histopathological Identification of Colon Cancer with Microsatellite Instability
Alexander, J., Watanabe, T., Wu, T., Rashid, A., Li, S., & Hamilton, S. R. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63994-6 · Cited by 510 · see citing works
Nosho, K., Baba, Y., Tanaka, N., Shima, K., Hayashi, M., Meyerhardt, J. A., Giovannucci, E., Dranoff, G., Fuchs, C. S., & Ogino, S. (2010) · The Journal of Pathology · doi:10.1002/path.2774 · Cited by 502 · see citing works
Flanagan, L., Schmid, J., Ebert, M., Soucek, P., Kunicka, T., Liska, V., Bruha, J., Neary, P., Dezeeuw, N., Tommasino, M., et al. (2014) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-014-2081-3 · Cited by 498 · see citing works
The role of the microbiome in exacerbations of chronic lung diseases
Dickson, R. P., Martinez, F. J., & Huffnagle, G. B. (2014) · The Lancet · doi:10.1016/s0140-6736(14)61136-3 · Cited by 495 · see citing works
<i>Fusobacterium</i> in Colonic Flora and Molecular Features of Colorectal Carcinoma
Tahara, T., Yamamoto, E., Suzuki, H., Maruyama, R., Chung, W., Garriga, J., Jelinek, J., Yamano, H.-O., Sugai, T., An, B., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-1865 · Cited by 465 · see citing works
Ogino, S., Nosho, K., Irahara, N., Meyerhardt, J. A., Baba, Y., Shima, K., Glickman, J. N., Ferrone, C. R., Mino-Kenudson, M. A., Tanaka, N., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1438 · Cited by 418 · see citing works
Michaud, D. S., Izard, J., Wilhelm-Benartzi, C. S., You, D.-H., Grote, V. A., Tjønneland, A. M., Dahm, C. C., Overvad, K., Jenab, M., Fedirko, V., et al. (2012) · Gut · doi:10.1136/gutjnl-2012-303006 · Cited by 407 · see citing works
Mitsuhashi, K., Nosho, K., Sukawa, Y., Matsunaga, Y., Ito, M., Kurihara, H., Kanno, S., Igarashi, H., Naito, T., Adachi, Y., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3109 · Cited by 404 · see citing works
Schwitalle, Y., Kloor, M., Eiermann, S., Linnebacher, M., Kienle, P., Knaebel, H. P., Tariverdian, M., Benner, A., & Doeberitz, M. V. K. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.01.015 · Cited by 386 · see citing works
Jenkins, M. A., Hayashi, S., O’Shea, A.-M., Burgart, L. J., Smyrk, T., Shimizu, D. M., Waring, P. M., Ruszkiewicz, A. R., Pollett, A. F., Redston, M. S., et al. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.04.044 · Cited by 374 · see citing works
Merline, R., Moreth, K., Beckmann, J., Nastase, M. V., Zeng-Brouwers, J., Tralhão, J. G., Lemarchand, P., Pfeilschifter, J., Schaefer, R. M., Iozzo, R. V., et al. (2011) · Science Signaling · doi:10.1126/scisignal.2001868 · Cited by 333 · see citing works
Fusobacterium nucleatumin Periodontal Health and Disease
Signat, B., Roques, C. G., Poulet, P. P., & Duffaut, D. (2011) · Current Issues in Molecular Biology · doi:10.21775/cimb.013.025 · Cited by 332 · see citing works
Sinicrope, F. A., Rego, R. L., Ansell, S. M., Knutson, K. L., Foster, N. R., & Sargent, D. J. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.06.053 · Cited by 329 · see citing works
Ohkusa, T., Okayasu, I., Ogihara, T., Morita, K., Ogawa, M., & Sato, N. (2002) · Gut · doi:10.1136/gut.52.1.79 · Cited by 300 · see citing works
Control of metastatic progression by microRNA regulatory networks
Pencheva, N., & Tavazoie, S. F. (2013) · Nature Cell Biology · doi:10.1038/ncb2769 · Cited by 295 · see citing works
Cancer immunology—analysis of host and tumor factors for personalized medicine
Ogino, S., Galon, J., Fuchs, C. S., & Dranoff, G. (2011) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2011.122 · Cited by 284 · see citing works
Shia, J., Ellis, N. A., Paty, P. B., Nash, G. M., Qin, J., Offit, K., Zhang, X.-M., Markowitz, A. J., Nafa, K., Guillem, J. G., et al. (2003) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200311000-00002 · Cited by 222 · see citing works
Mao, Y., Poschke, I. C., Wennerberg, E., de Coaña, Y. P., Brage, S. E., Schultz, I., Hansson, J., Masucci, G. V., Lundqvist, A., & Kiessling, R. W. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4115 · Cited by 192 · see citing works
Wang, P., Zhuang, L., Zhang, J., Fan, J., Luo, J., Chen, H., Wang, K., Liu, L., Chen, Z., & Meng, Z. (2012) · Molecular Oncology · doi:10.1016/j.molonc.2012.10.011 · Cited by 186 · see citing works
Fusobacterium nucleatum Outer Membrane Proteins Fap2 and RadD Induce Cell Death in Human Lymphocytes
Kaplan, C. W., Ma, X., Paranjpe, A., Jewett, A., Lux, R., Haake, S. K., & Shi, W. (2010) · Infection and Immunity · doi:10.1128/iai.00567-10 · Cited by 182 · see citing works
Nosho, K., Kure, S., Irahara, N., Shima, K., Baba, Y., Spiegelman, D. L., Meyerhardt, J. A., Giovannucci, E. L., Fuchs, C. S., & Ogino, S. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.08.002 · Cited by 173 · see citing works
Use of tumour-responsive T cells as cancer treatment
Disis, M. L., Bernhard, H., & Jaffee, E. M. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60404-9 · Cited by 164 · see citing works
Tougeron, D., Fauquembergue, É., Rouquette, A., Pessot, F. L., Sesboüé, R., Laurent, M., Berthet, P., Mauillon, J., Fiore, F. D., Sabourin, J., et al. (2009) · Modern Pathology · doi:10.1038/modpathol.2009.80 · Cited by 153 · see citing works
Role of bacterial infections in pancreatic cancer
Michaud, D. S. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt249 · Cited by 151 · see citing works
Dong, J., Zhao, Y.-P., Zhou, L., Zhang, T., & Chen, G. (2011) · Archives of Medical Research · doi:10.1016/j.arcmed.2011.01.006 · Cited by 150 · see citing works
Nagao, Y., Hisaoka, M., Matsuyama, A., Kanemitsu, S., Hamada, T., Fukuyama, T., Nakano, R., Uchiyama, A., Kawamoto, M., Yamaguchi, K., et al. (2011) · Modern Pathology · doi:10.1038/modpathol.2011.142 · Cited by 116 · see citing works
Association of microRNA-31 with BRAF mutation, colorectal cancer survival and serrated pathway
Nosho, K., Igarashi, H., Nojima, M., Ito, M., Maruyama, R., Yoshii, S., Naito, T., Sukawa, Y., Mikami, M., Sumioka, W., et al. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt374 · Cited by 112 · see citing works
Sempere, L. F., Preis, M., Yezefski, T., Ouyang, H., Suriawinata, A. A., Silahtaroglu, A., Conejo-Garcia, J. R., Kauppinen, S., Wells, W. A., & Korc, M. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1152 · Cited by 112 · see citing works
Suppression of human lymphocyte responses by oral spirochetes: a monocyte-dependent phenomenon.
Shenker, B. J., Listgarten, M. A., & Taichman, N. S. (1984) · The Journal of Immunology · doi:10.4049/jimmunol.132.4.2039 · Cited by 105 · see citing works
Jewett, A., Hume, W. R., Lê, H., Huynh, T. N., Han, Y. W., Cheng, G., & Shi, W. (2000) · Infection and Immunity · doi:10.1128/iai.68.4.1893-1898.2000 · Cited by 92 · see citing works
Shenker, B. J., & Datar, S. V. (1995) · Infection and Immunity · doi:10.1128/iai.63.12.4830-4836.1995 · Cited by 91 · see citing works
Hypoxia induces the overexpression of microRNA-21 in pancreatic cancer cells
Mace, T. A., Collins, A., Wojcik, S. E., Croce, C. M., Lesinski, G. B., & Bloomston, M. (2013) · Journal of Surgical Research · doi:10.1016/j.jss.2013.04.061 · Cited by 90 · see citing works
Ma, M., Kong, X., Weng, M., Cheng, K., Gong, W. J., Quan, Z.-W., & Peng, C. (2013) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-32-71 · Cited by 89 · see citing works
Baba, Y., Nosho, K., Shima, K., Huttenhower, C., Tanaka, N., Hazra, A., Giovannucci, E. L., Fuchs, C. S., & Ogino, S. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.07.050 · Cited by 88 · see citing works
MicroRNAs and Toll-like Receptor/Interleukin-1 Receptor Signaling
Virtue, A. T., Wang, H., & Yang, X. (2012) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-5-66 · Cited by 70 · see citing works
Farrell, J. J., Toste, P. A., Wu, N., Li, L., Wong, J. L., Malkhassian, D., Tran, L. M., Wu, X., Li, X., Dawson, D. W., et al. (2013) · The American Journal of Gastroenterology · doi:10.1038/ajg.2013.167 · Cited by 70 · see citing works
Igarashi, H., Kurihara, H., Mitsuhashi, K., Ito, M., Okuda, H., Kanno, S., Naito, T., Yoshii, S., Takahashi, H., Kusumi, T., et al. (2014) · Annals of Surgical Oncology · doi:10.1245/s10434-014-4264-7 · Cited by 63 · see citing works
miR-21 Targets 15-PGDH and Promotes Cholangiocarcinoma Growth
Lu, L., Byrnes, K., Han, C. L., Wang, Y., & Wu, T. (2014) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-13-0419 · Cited by 63 · see citing works
Liver abscess caused by periodontal bacterial infection with Fusobacterium necrophorum
Yoneda, M., Kato, S., Mawatari, H., Kirikoshi, H., Imajo, K., Fujita, K., Endo, H., Takahashi, H., Inamori, M., Kobayashi, N., et al. (2011) · Hepatology Research · doi:10.1111/j.1872-034x.2010.00748.x · Cited by 52 · see citing works
Microbiological Analysis of Pancreatic Abscess
Brook, I., & Frazier, E. H. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/22.2.384 · Cited by 51 · see citing works
Ito, M., Mitsuhashi, K., Igarashi, H., Nosho, K., Naito, T., Yoshii, S., Takahashi, H., Fujita, M., Sukawa, Y., Yamamoto, E., et al. (2014) · International Journal of Cancer · doi:10.1002/ijc.28920 · Cited by 49 · see citing works
Mitsuhashi, K., Yamamoto, I., Kurihara, H., Kanno, S., Ito, M., Igarashi, H., Ishigami, K., Sukawa, Y., Tachibana, M., Takahashi, H., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4294 · Cited by 43 · see citing works
A microRNA meta-signature for pancreatic ductal adenocarcinoma
Frampton, A. E., Giovannetti, E., Jamieson, N. B., Krell, J., Gall, T., Stebbing, J., Jiao, L. R., & Castellano, L. (2014) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.2014.893192 · Cited by 34 · see citing works
Liver Abscesses due to Fusobacterium spp. that Mimick Malignant Metastatic Liver Disease
Athavale, N. V., Leitch, D. G., & Cowling, P. (2002) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-002-0844-8 · Cited by 27 · see citing works
Shenker, B. J., & Matt, W. C. (1987) · Immunopharmacology · doi:10.1016/0162-3109(87)90028-2 · Cited by 26 · see citing works
Hansen, T. F., Kjær‐Frifeldt, S., Christensen, R., Morgenthaler, S., Blöndal, T., Lindebjerg, J., Sørensen, F. B., & Jakobsen, A. K. M. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.409 · Cited by 25 · see citing works
O'Callaghan, G. P., Ryan, A. E., Neary, P., O’Mahony, C., Shanahan, F., & Houston, A. M. (2013) · International Journal of Cancer · doi:10.1002/ijc.28076 · Cited by 24 · see citing works
Seroprevalence ofFusobacterium variumin ulcerative colitis patients in Japan
Minami, M., Ando, T., Okamoto, A., Sasaki, N., Ohkura, T., Torii, K., Hasegawa, T., Ohta, M., & Goto, H. (2009) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2009.00550.x · Cited by 22 · see citing works
Honda, T., Takahashi, N., Miyauchi, S., & Yamazaki, K. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.03.102 · Cited by 22 · see citing works
The Role of Aggregation in Fusobacterium nucleatum– induced Immune Cell Death
Huynh, T. N., Kapur, R. V., Kaplan, C. W., Cacalano, N. A., Haake, S. K., Shi, W., Sieling, P. A., & Jewett, A. (2011) · Journal of Endodontics · doi:10.1016/j.joen.2011.06.034 · Cited by 22 · see citing works
Haake, S. K., & Lindemann, R. A. (1997) · Journal of Periodontology · doi:10.1902/jop.1997.68.1.39 · Cited by 21 · see citing works
Fusobacterium necrophorum – beyond Lemierres syndrome: Figure 1
Shahani, L., & Khardori, N. M. (2011) · BMJ Case Reports · doi:10.1136/bcr.07.2011.4527 · Cited by 21 · see citing works
Naito, T. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i29.10050 · Cited by 16 · see citing works
Clinicopathological and Molecular Characteristics of Serrated Lesions in Japanese Elderly Patients
Nosho, K., Igarashi, H., Ito, M., Mitsuhashi, K., Kurihara, H., Kanno, S., Yoshii, S., Mikami, M., Takahashi, H., Kusumi, T., et al. (2015) · Digestion · doi:10.1159/000368820 · Cited by 13 · see citing works
Speetjens, F. M., Kuppen, P. J. K., Morreau, H., & van der Burg, S. H. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.04.040 · Cited by 11 · see citing works
MicroRNA-31 expression in colorectal serrated pathway progression
Aoki, H. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i34.12346 · Cited by 8 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Colorectal Carcinoma: A General Overview and Future Perspectives in Colorectal Cancer
Mármol, I., Sánchez‐de‐Diego, C., Pradilla-Dieste, A., Cerrada, E., & Yoldi, M. R. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18010197 · Cited by 1,559 · see citing works
Diet, microorganisms and their metabolites, and colon cancer
O'Keefe, S. J. D. (2016) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2016.165 · Cited by 1,100 · see citing works
Yang, Y. P., Weng, W., Peng, J., Hong, L., Yang, L., Toiyama, Y., Gao, R., Liu, M., Yin, M., Pan, C., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.11.018 · Cited by 1,015 · see citing works
The Intestinal Microbiota in Colorectal Cancer.
Tilg, H., Adolph, T. E., Gerner, R. R., & Moschen, A. R. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.03.004 · Cited by 777 · see citing works
Influence of the Gut Microbiome, Diet, and Environment on Risk of Colorectal Cancer
Song, M., Chan, A. T., & Sun, J. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.06.048 · Cited by 752 · see citing works
Colorectal Cancer and Nutrition
Thanikachalam, K., & Khan, G. N. (2019) · Nutrients · doi:10.3390/nu11010164 · Cited by 749 · see citing works
Intestinal flora and disease mutually shape the regional immune system in the intestinal tract
Zhou, B., Yuan, Y., Zhang, S., Guo, C., Li, X., Li, G., Xiong, W., & Zeng, Z. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00575 · Cited by 396 · see citing works
Casasanta, M. A., Yoo, C. C., Udayasuryan, B., Sanders, B. E., Umaña, A., Zhang, Y., Peng, H., Duncan, A. J., Wang, Y., Li, L., et al. (2020) · Science Signaling · doi:10.1126/scisignal.aba9157 · Cited by 324 · see citing works
Mehta, R. S., Nishihara, R., Cao, Y., Song, M., Mima, K., Qian, Z. R., Nowak, J. A., Kosumi, K., Hamada, T., Masugi, Y., et al. (2017) · JAMA Oncology · doi:10.1001/jamaoncol.2016.6374 · Cited by 325 · see citing works
The oral–gut microbiome axis in health and disease
Kunath, B. J., Rudder, C. D., Laczny, C. C., Letellier, E., & Wilmes, P. (2024) · Nature Reviews Microbiology · doi:10.1038/s41579-024-01075-5 · Cited by 342 · see citing works
Gut Microbiota in Cancer Immune Response and Immunotherapy
Zhou, C., Zhou, Y., & Fang, J. (2021) · Trends in cancer · doi:10.1016/j.trecan.2021.01.010 · Cited by 303 · see citing works
Xu, C., Fan, L., Lin, Y., Shen, W., Qi, Y., Zhang, Y., Chen, Z., Wang, L., Long, Y., Hou, T., et al. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1980347 · Cited by 294 · see citing works
Zhang, X., Dou, Y., Wu, D., Gao, X., Shao, F., Zhao, M., Wang, J., Ma, J., Wang, W., Qin, X., et al. (2023) · Cell Host & Microbe · doi:10.1016/j.chom.2023.01.013 · Cited by 287 · see citing works
Fusobacterium nucleatum in colorectal carcinoma tissue according to tumor location
Mima, K., Cao, Y., Chan, A. T., Qian, Z. R., Nowak, J. A., Masugi, Y., Shi, Y., Song, M., da Silva, A., Gu, M., et al. (2016) · Clinical and Translational Gastroenterology · doi:10.1038/ctg.2016.53 · Cited by 284 · see citing works
Hsieh, Y.-Y., Tung, S.-Y., Pan, H.-Y., Yen, C.-W., Xu, H.-W., Lin, Y.-J., Deng, Y.-F., Hsu, W.-T., Wu, C.-S., & Li, C. (2018) · Scientific Reports · doi:10.1038/s41598-017-18596-0 · Cited by 269 · see citing works
<i>Fusobacterium nucleatum</i>and colorectal cancer: A review
Shang, F.-M., & Liu, H.-L. (2018) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v10.i3.71 · Cited by 258 · see citing works
Ogino, S., Nowak, J. A., Hamada, T., Milner, D. A., & Nishihara, R. (2018) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-012418-012818 · Cited by 256 · see citing works
Microbiome in Colorectal Cancer: How to Get from Meta-omics to Mechanism?
Ternes, D., Karta, J., Tsenkova, M., Wilmes, P., Haan, S., & Letellier, E. (2020) · Trends in Microbiology · doi:10.1016/j.tim.2020.01.001 · Cited by 256 · see citing works
Hamada, T., Zhang, X., Mima, K., Bullman, S., Sukawa, Y., Nowak, J. A., Kosumi, K., Masugi, Y., Twombly, T. S., Cao, Y., et al. (2018) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-18-0174 · Cited by 232 · see citing works
Distinct gut microbiome patterns associate with consensus molecular subtypes of colorectal cancer
Purcell, R. V., Visnovska, M., Biggs, P. J., Schmeier, S., & Frizelle, F. A. (2017) · Scientific Reports · doi:10.1038/s41598-017-11237-6 · Cited by 227 · see citing works
Hallmarks of cancer—the new testament
Senga, S. S., & Grose, R. P. (2021) · Open Biology · doi:10.1098/rsob.200358 · Cited by 221 · see citing works
Hanus, M., Parada‐Venegas, D., Landskron, G., Wielandt, A. M., Hurtado, C., Álvarez, K., Hermoso, M. A., López-Köstner, F., & la Fuente, M. D. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.612826 · Cited by 201 · see citing works
Role of SCFAs in gut microbiome and glycolysis for colorectal cancer therapy
Wang, G., Yu, Y., Wang, Y., Wang, J., Guan, R., Sun, Y., Shi, F., Gao, J., & Fu, X. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28436 · Cited by 199 · see citing works
Fusobacterium nucleatum and cancer
Alon‐Maimon, T., Mandelboim, O., & Bachrach, G. (2022) · Periodontology 2000 · doi:10.1111/prd.12426 · Cited by 200 · see citing works
Bourgeois, D. M., Inquimbert, C., Ottolenghi, L., & Carrouel, F. (2019) · Microorganisms · doi:10.3390/microorganisms7100424 · Cited by 190 · see citing works
Microbial dysbiosis in the gut drives systemic autoimmune diseases
Mousa, W. K., Chehadeh, F., & Husband, S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.906258 · Cited by 207 · see citing works
The oral microbiota – a mechanistic role for systemic diseases
Jia, G., Zhi, A., Lai, P. F. H., Wang, G., Xia, Y., Xiong, Z., Zhang, H., Che, N., & Ai, L. (2018) · BDJ · doi:10.1038/sj.bdj.2018.217 · Cited by 183 · see citing works
Integrative analysis of exogenous, endogenous, tumour and immune factors for precision medicine
Ogino, S., Nowak, J. A., Hamada, T., Phipps, A. I., Peters, U., Milner, D. A., Giovannucci, E. L., Nishihara, R., Giannakis, M., Garrett, W. S., et al. (2018) · Gut · doi:10.1136/gutjnl-2017-315537 · Cited by 169 · see citing works
Fan, Z., Tang, P., Li, C., Yang, Q., Xu, Y., Su, C., & Li, L. (2023) · Journal of Oral Microbiology · doi:10.1080/20002297.2022.2145729 · Cited by 150 · see citing works
Gut Microbiota, Fusobacteria, and Colorectal Cancer
Kelly, D., Yang, L., & Pei, Z. (2018) · Diseases · doi:10.3390/diseases6040109 · Cited by 145 · see citing works
Amitay, E. L., Werner, S., Vital, M., Pieper, D. H., Höfler, D., Gierse, I.-J., Butt, J., Balavarca, Y., Ćuk, K., & Brenner, H. (2017) · Carcinogenesis · doi:10.1093/carcin/bgx053 · Cited by 138 · see citing works
Exploring the Role of Gut Microbiome in Colon Cancer
Chattopadhyay, I., Dhar, R., Pethusamy, K., Seethy, A. A., Srivastava, T. P., Sah, R., Sharma, J. N., & Karmakar, S. (2021) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-021-03498-9 · Cited by 139 · see citing works
Fusobacterium and Colorectal Cancer
Zhou, Z., Chen, J., Yao, H., & Hu, H. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00371 · Cited by 137 · see citing works
Structure and Function of the Fecal Microbiota in Diarrheic Neonatal Piglets
Yang, Q., Huang, X., Zhao, S., Sun, W., Yan, Z., Wang, P., Li, S., Huang, W., Zhang, S., Liu, L., et al. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.00502 · Cited by 128 · see citing works
Neuzillet, C., Marchais, M., Vacher, S., Hilmi, M., Schnitzler, A., Meseure, D., Leclère, R., Lecerf, C., Dubot, C., Jeannot, E., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-86816-9 · Cited by 128 · see citing works
Stress and cancer: The mechanisms of immune dysregulation and management
Liu, Y., Tian, S., Ning, B., Huang, T., Li, Y., & Wei, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1032294 · Cited by 135 · see citing works
Liu, L., Tabung, F. K., Zhang, X., Nowak, J. A., Qian, Z. R., Hamada, T., Nevo, D., Bullman, S., Mima, K., Kosumi, K., et al. (2018) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2018.04.030 · Cited by 117 · see citing works
Gut Microbiome: A Promising Biomarker for Immunotherapy in Colorectal Cancer
Temraz, S. N., Nassar, F. J., Nasr, R., Charafeddine, M., Mukherji, D., & Shamseddine, A. I. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20174155 · Cited by 119 · see citing works
Microbiota modification by probiotic supplementation reduces colitis associated colon cancer in mice
Mendes, M. C. S., Paulino, D. S., Brambilla, S. R., Camargo, J. A., Persinoti, G. F., & Carvalheira, J. B. C. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i18.1995 · Cited by 116 · see citing works
Rajpoot, M., Sharma, A. K., Sharma, A. K., & Gupta, G. K. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2018.02.003 · Cited by 116 · see citing works
Gomes, S., Oliveira, C. S., Azevedo‐Silva, J., Casanova, M. R., Barreto, J., Pereira, H., Chaves, S. R., Rodrigues, L. R., Casal, M., Côrte‐Real, M., et al. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867325666180530102050 · Cited by 116 · see citing works
Yang, Y., Chen, G., Yang, Q., Ye, J., Cai, X., Tsering, P., Cheng, X., Hu, C., Zhang, S., & Cao, P. (2017) · Oncotarget · doi:10.18632/oncotarget.16458 · Cited by 110 · see citing works
The colorectal cancer immune microenvironment and approach to immunotherapies
Koi, M., & Carethers, J. M. (2017) · Future Oncology · doi:10.2217/fon-2017-0145 · Cited by 109 · see citing works
Proença, M. A., Biselli, J. M., Succi, M., Severino, F. E., Berardinelli, G. N., Caetano, A., Reis, R. M., Hughes, D. J., & Silva, A. E. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i47.5351 · Cited by 109 · see citing works
Tea polyphenols and their chemopreventive and therapeutic effects on colorectal cancer
Wang, S.-T., Cui, W., Pan, D., Jiang, M., Chang, B., & Sang, L.-X. (2020) · World Journal of Gastroenterology · doi:10.3748/wjg.v26.i6.562 · Cited by 110 · see citing works
The oral cavity microbiota: between health, oral disease, and cancers of the aerodigestive tract
Bars, P. L. L., Matamoros, S., Montassier, E., Vacon, F. L., Potel, G., Soueidan, A., Jordana, F., & de la Cochetière, M.-F. (2017) · Canadian Journal of Microbiology · doi:10.1139/cjm-2016-0603 · Cited by 108 · see citing works
Borowsky, J., Haruki, K., Lau, M. C., Costa, A. D., Väyrynen, J. P., Ugai, T., Arima, K., da Silva, A., Felt, K. D., Zhao, M. M., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-4009 · Cited by 104 · see citing works
Wang, H., Li, L., Guo, S., Zeng, Q., Ning, F., Liu, W., & Zhang, G. (2016) · Scientific Reports · doi:10.1038/srep33440 · Cited by 102 · see citing works
Li, Y., Xing, S., Chen, F., Li, Q., Dou, S., Huang, Y., An, J., Liu, W., & Zhang, G. (2023) · Nature Communications · doi:10.1038/s41467-023-40987-3 · Cited by 102 · see citing works
Hamada, T., Nowak, J. A., Milner, D. A., Song, M., & Ogino, S. (2019) · The Journal of Pathology · doi:10.1002/path.5236 · Cited by 100 · see citing works
In Silico Analysis of Putrefaction Pathways in Bacteria and Its Implication in Colorectal Cancer
Kaur, H., Das, C., & Mande, S. S. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.02166 · Cited by 99 · see citing works
Comparison Between the Fecal Bacterial Microbiota of Healthy and Diarrheic Captive Musk Deer
Li, Y., Hu, X., Yang, S., Zhou, J., Qi, L., Sun, X., Fan, M., Xu, S., Cha, M., Zhang, M., et al. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00300 · Cited by 97 · see citing works
Gut microbiome associated with APC gene mutation in patients with intestinal adenomatous polyps
Liang, S., Mao, Y. K., Liao, M., Xu, Y., Chen, Y.-C., Huang, X., Wei, C., Wu, C., Wang, Q., Pan, X., et al. (2019) · International Journal of Biological Sciences · doi:10.7150/ijbs.37399 · Cited by 96 · see citing works
Lee, D., Han, S., Kang, J., Bae, J. M., Kim, H., Won, J., Jeong, S., Park, K. J., Kang, G. H., & Kim, T. (2018) · Annals of Surgical Oncology · doi:10.1245/s10434-018-6681-5 · Cited by 95 · see citing works
Ranjbar, M., Salehi, R., Javanmard, S. H., Rafiee, L., Faraji, H., jafarpor, S., Ferns, G. A., Ghayour‐Mobarhan, M., Manian, M., & Nedaeinia, R. (2021) · Cancer Cell International · doi:10.1186/s12935-021-01886-z · Cited by 95 · see citing works
Li, J., Zhang, A., Wu, F., & Wang, X. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.841552 · Cited by 96 · see citing works
Morgillo, F., Dallio, M., Corte, C. M. D., Gravina, A. G., Viscardi, G., Loguercio, C., Ciardiello, F., & Federico, A. (2018) · Neoplasia · doi:10.1016/j.neo.2018.05.002 · Cited by 94 · see citing works
Characteristics of the Salivary Microbiota in Patients With Various Digestive Tract Cancers
Kageyama, S., Takeshita, T., Takeuchi, K., Asakawa, M., Matsumi, R., Furuta, M., Shibata, Y., Nagai, K., Ikebe, M., Morita, M., et al. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.01780 · Cited by 91 · see citing works
Yang, Q., Huang, X., Wang, P., Yan, Z., Sun, W., Zhao, S., & Gun, S. (2019) · MicrobiologyOpen · doi:10.1002/mbo3.923 · Cited by 83 · see citing works
Sakamoto, Y., Mima, K., Ishimoto, T., Ogata, Y., Imai, K., Miyamoto, Y., Akiyama, T., Daitoku, N., Hiyoshi, Y., Iwatsuki, M., et al. (2021) · Cancer Science · doi:10.1111/cas.15126 · Cited by 83 · see citing works
Role of oral and gut microbiome in nitric oxide-mediated colon motility
Walker, M., Pratap, S., Southerland, J. H., Farmer‐Dixon, C. M., Kesavalu, L. N., & Gangula, P. R. (2017) · Nitric Oxide · doi:10.1016/j.niox.2017.06.003 · Cited by 81 · see citing works
Bi, K., Zhang, X., Chen, W., & Diao, H. (2020) · Genes · doi:10.3390/genes11091075 · Cited by 81 · see citing works
The Human Microbiome in Relation to Cancer Risk: A Systematic Review of Epidemiologic Studies
Huybrechts, I., Zouiouich, S., Loobuyck, A., Vandenbulcke, Z., Vogtmann, E., Pisanu, S., Iguacel, I., Scalbert, A., Indave, I., Smelov, V., et al. (2020) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-20-0288 · Cited by 80 · see citing works
Yamamoto, H., & Imai, K. (2019) · Seminars in Oncology · doi:10.1053/j.seminoncol.2019.08.003 · Cited by 74 · see citing works
Fusobacterium’s link to colorectal neoplasia sequenced: A systematic review and future insights
Hussan, H., Clinton, S. K., Roberts, K., & Bailey, M. T. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i48.8626 · Cited by 73 · see citing works
Koi, M., Okita, Y., & Carethers, J. M. (2018) · Journal of the Anus Rectum and Colon · doi:10.23922/jarc.2017-055 · Cited by 76 · see citing works
Association between Fusobacterium nucleatum and colorectal cancer: Progress and future directions
Zhang, S., Cai, S., & Ma, Y. (2018) · Journal of Cancer · doi:10.7150/jca.24048 · Cited by 73 · see citing works
Fusobacterium nucleatum in tumors: from tumorigenesis to tumor metastasis and tumor resistance
Ye, C., Liu, X., Liu, Z., Pan, C., Zhang, X., Zhao, Z., & Sun, H. (2024) · Cancer Biology & Therapy · doi:10.1080/15384047.2024.2306676 · Cited by 72 · see citing works
Analysis of oral microbiota in Japanese oral cancer patients using 16S rRNA sequencing
Takahashi, Y., Park, J., Hosomi, K., Yamada, T., Kobayashi, A., Yamaguchi, Y., Iketani, S., Kunisawa, J., Mizuguchi, K., Maeda, N., et al. (2019) · Journal of Oral Biosciences · doi:10.1016/j.job.2019.03.003 · Cited by 68 · see citing works
Li, G., Sun, Y., Huang, Y., Lian, J., Wu, S., Luo, D., & Gong, H. (2023) · BMC Cancer · doi:10.1186/s12885-023-10844-z · Cited by 69 · see citing works
Osman, M. A., Neoh, H., Mutalib, N. A., Chin, S., & Jamal, R. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00767 · Cited by 66 · see citing works
Intestinal microbiota: a novel perspective in colorectal cancer biotherapeutics
Ding, C., Tang, W., Fan, X., & Wu, G. (2018) · OncoTargets and Therapy · doi:10.2147/ott.s170626 · Cited by 66 · see citing works
Randrian, V., Evrard, C., & Tougeron, D. (2021) · Cancers · doi:10.3390/cancers13123063 · Cited by 65 · see citing works
Oral microbiota and Helicobacter pylori in gastric carcinogenesis: what do we know and where next?
Bakhti, S. Z., & Latifi‐Navid, S. (2021) · BMC Microbiology · doi:10.1186/s12866-021-02130-4 · Cited by 66 · see citing works
Inamura, K. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.06.006 · Cited by 62 · see citing works
Tumor-Associated Microbiome: Where Do We Stand?
Oliva, M., Mulet-Margalef, N., Ochoa-de-Olza, M., Napoli, S., Mas-Lloret, J., Laquente, B., Alemany, L., Duell, E. J., Nuciforo, P. G., & Moreno, V. R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031446 · Cited by 62 · see citing works
Targeting Immune-Related Biological Processes in Solid Tumors: We do Need Biomarkers
Pagni, F., Guerini‐Rocco, E., Schultheis, A. M., Grazia, G., Rijavec, E., Ghidini, M., Lopez, G., Venetis, K., Croci, G. A., Malapelle, U., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20215452 · Cited by 61 · see citing works
Yu, D., Liu, X., Han, G., Liu, Y., Zhao, X., Wang, D., Bian, X., Gu, T., & Wen, L. (2019) · Cell Communication and Signaling · doi:10.1186/s12964-019-0490-8 · Cited by 62 · see citing works
de Carvalho, A. C., Pereira, L. D. M., Datorre, J. G., dos Santos, W., Berardinelli, G. N., Matsushita, M. D. M., de Oliveira, M. A., Durães, R. O., Guimarães, D. P., & Reis, R. M. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00813 · Cited by 63 · see citing works
Lee, J. A., Yoo, S.-Y., Oh, H. J., Jeong, S., Cho, N.-Y., Kang, G. H., & Kim, J. H. (2021) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-020-02657-x · Cited by 61 · see citing works
Pignatelli, P., Iezzi, L., Pennese, M., Raimondi, P., Cichella, A., Bondi, D., Grande, R., Cotellese, R., Bartolomeo, N. D., Innocenti, P., et al. (2021) · Cancers · doi:10.3390/cancers13051032 · Cited by 58 · see citing works
Borozan, I., Zaidi, S. H., Harrison, T. A., Phipps, A. I., Zheng, J., Lee, S., Trinh, Q. M., Steinfelder, R. S., Adams, J., Banbury, B. L., et al. (2022) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-21-0463 · Cited by 57 · see citing works
Uchino, Y., Goto, Y., Konishi, Y., Tanabe, K., Toda, H., Wada, M., Kita, Y., Beppu, M., Mori, S., Hijioka, H., et al. (2021) · Cancers · doi:10.3390/cancers13133332 · Cited by 57 · see citing works
Targeting Programmed Fusobacterium nucleatum Fap2 for Colorectal Cancer Therapy
Ganesan, K., Guo, S., Fayyaz, S., Zhang, G., & Xu, B. (2019) · Cancers · doi:10.3390/cancers11101592 · Cited by 58 · see citing works
Microbiome and colorectal carcinogenesis: Linked mechanisms and racial differences
Tortora, S. C., Bodiwala, V., Quinn, A., Martello, L. A., & Vignesh, S. (2022) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v14.i2.375 · Cited by 58 · see citing works
Food, microbiome and colorectal cancer
Niederreiter, L., Adolph, T. E., & Tilg, H. (2018) · Digestive and Liver Disease · doi:10.1016/j.dld.2018.03.030 · Cited by 56 · see citing works
Fusobacterium�nucleatum promotes the progression of colorectal cancer by interacting with E‑cadherin
Ma, C., Luo, H., Gao, F., Tang, Q., & Chen, W. (2018) · Oncology Letters · doi:10.3892/ol.2018.8947 · Cited by 56 · see citing works
Tunsjø, H. S., Gundersen, G., Rangnes, F., Noone, J. C., Endres, A., & Bemanian, V. (2019) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-019-03562-7 · Cited by 55 · see citing works
Microbiota-Associated Metabolites and Related Immunoregulation in Colorectal Cancer
Chen, Y., & Chen, Y. (2021) · Cancers · doi:10.3390/cancers13164054 · Cited by 54 · see citing works
The gut dysbiosis-cancer axis: illuminating novel insights and implications for clinical practice
Asseri, A. H., Bakhsh, T., Abuzahrah, S. S., Ali, S., & Rather, I. A. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1208044 · Cited by 54 · see citing works
Tsuchiya, Y., Loza, E., Villa‐Gomez, G., Trujillo, C. C., Báez, S., Asai, T., Ikoma, T., Endoh, K., & Nakamura, K. (2018) · Europe PMC (PubMed Central) · doi:10.22034/apjcp.2018.19.4.961 · Cited by 54 · see citing works
Fusobacterium nucleatum and Colorectal Cancer
Li, R., Shen, J., & Xu, Y. (2022) · Infection and Drug Resistance · doi:10.2147/idr.s357922 · Cited by 53 · see citing works
Koi, M., Tseng-Rogenski, S. S., & Carethers, J. M. (2018) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v10.i1.1 · Cited by 50 · see citing works
Younginger, B. S., Mayba, O., Reeder, J., Nagarkar, D. R., Modrusan, Z. D., Albert, M. L., & Byrd, A. L. (2023) · Cell Reports Medicine · doi:10.1016/j.xcrm.2023.100920 · Cited by 47 · see citing works
Tumor LINE-1 methylation level and colorectal cancer location in relation to patient survival
Mima, K., Nowak, J. A., Qian, Z. R., Cao, Y., Song, M., Masugi, Y., Shi, Y. X., da Silva, A., Gu, M., Li, W., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.10398 · Cited by 47 · see citing works
Dual Role of Bacteria in Carcinoma: Stimulation and Inhibition
Al-Hilu, S. A., & Al-Shujairi, W. H. (2020) · International Journal of Microbiology · doi:10.1155/2020/4639761 · Cited by 47 · see citing works
Foes or Friends? Bacteria Enriched in the Tumor Microenvironment of Colorectal Cancer
Xu, S., Yin, W., Zhang, Y., Lv, Q., Yang, Y., & He, J. (2020) · Cancers · doi:10.3390/cancers12020372 · Cited by 47 · see citing works
Jin, K., Chen, B., Liu, Y., Lan, H., & Yan, J. (2021) · Cancer Cell International · doi:10.1186/s12935-021-01763-9 · Cited by 46 · see citing works
Gut Microbiota–MicroRNA Interactions in Intestinal Homeostasis and Cancer Development
Nikolaieva, N., Ševčíková, A., Omelka, R., Martiniaková, M., Mego, M., & Čierniková, S. (2022) · Microorganisms · doi:10.3390/microorganisms11010107 · Cited by 47 · see citing works
Progress in characterizing the linkage between Fusobacterium nucleatum and gastrointestinal cancer
Liu, Y., Baba, Y., Ishimoto, T., Iwatsuki, M., Hiyoshi, Y., Miyamoto, Y., Yoshida, N., Wu, R., & Baba, H. (2018) · Journal of Gastroenterology · doi:10.1007/s00535-018-1512-9 · Cited by 47 · see citing works
- Authors
- Nosho, K.
- Affiliations
- Sapporo Medical University (JP)
- Corresponding author
- Nosho, Katsuhiko
- Venue
- World Journal of Gastroenterology
- Publisher
- Baishideng Publishing Group Inc.
- Published
- 2016
- Volume
- 22
- Issue
- 2
- Pages
- 557
- ISSN
- 1007-9327 (ISSN-L)
- PMC
- PMC4716059
- OpenAlex
- W2298181742
- Cited by
- 344
- References
- 99
- Citations by year
- 2026: 16 · 2025: 22 · 2024: 34 · 2023: 47 · 2022: 49 · 2021: 46 · 2020: 36 · 2019: 33 · 2018: 36 · 2017: 17 · 2016: 8
- FWCI
- 2.83
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- Locations
- World Journal of Gastroenterology (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Pancreas Research Foundation of Japan
- Japan Society for the Promotion of Science (221S0001, 25670371, 26640101)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
- Keywords
- Fusobacterium nucleatum, colorectal cancer, gut microbiota, microsatellite instability, antitumor immunity, T cell infiltration, immunosuppression, myeloid-derived cells, miR-21, IL-10, prostaglandin E2, dendritic cells, Japanese patients
- MeSH terms
- Gastrointestinal Microbiome, Animals, Fusobacterium Infections, Humans, Immunity, Innate, Lymphocyte Activation, Biomarkers, Tumor, Colorectal Neoplasms, T-Lymphocyte Subsets, Lymphocytes, Tumor-Infiltrating, Fusobacterium nucleatum, Tumor Escape, Microsatellite Instability, Host-Pathogen Interactions, Adaptive Immunity, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
